Scisparc announces israeli ministry of health approval to conduct its clinical trial in autism spectrum disorder

The trial's objectives are to evaluate the safety, tolerability and efficacy of scisparc's sci-210 in children and adolescents with asd

SPRC Ratings Summary

SPRC Quant Ranking